This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Galapagos Nv. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2025
Title: **Innovator Spotlight: Steve Irma Joel De Vos**
Introduction
Steve Irma Joel De Vos, an influential inventor based in Mechelen, Belgium, has made noteworthy contributions to the field of pharmaceuticals. With a patent to his name, he is dedicated to enhancing the treatment options available for various diseases.
Latest Patents
Steve holds a significant patent titled "Compounds useful for the treatment of metabolic and inflammatory diseases." This innovative work details compounds with specific formulas that have potential applications in pharmaceutical compositions. These compounds are designed for the prevention and treatment of a range of conditions in mammals, including inflammatory conditions, infectious diseases, autoimmune diseases, disorders affecting immune cell functions, cardiometabolic diseases, and proliferative diseases. His inventive solutions present promising avenues for alleviating suffering in affected individuals.
Career Highlights
Steve is currently employed by Galapagos NV, a prominent biotechnology company known for its groundbreaking research and development in novel therapies. His work in the company showcases his commitment to addressing critical health issues through innovative scientific endeavors. The knowledge and expertise he brings to his role significantly contribute to advancing the company's mission in addressing unmet medical needs.
Collaborations
Throughout his career, Steve has collaborated with esteemed colleagues, including Laurent Raymond Maurice Sanière and Mathieu Rafaël Pizzonero. These partnerships emphasize a shared commitment to innovation and propel the collective efforts toward impactful scientific research and discovery.
Conclusion
Steve Irma Joel De Vos exemplifies the spirit of innovation within the pharmaceutical industry. His patent contributions and collaborations with talented coworkers highlight the importance of teamwork in driving forward groundbreaking inventions that can significantly improve health outcomes globally. As he continues his work, the potential for his compounds to influence the treatment of various diseases remains a testament to the power of dedicated research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile